Alnylam Pharmaceuticals
ALNY
#443
Rank
A$79.94 B
Marketcap
A$605.11
Share price
1.06%
Change (1 day)
57.92%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: A$742.68 AUD on 2025-10-20

Lowest end of day price: A$5.97 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 71.32%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$103.05 2.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,161 2.57%๐Ÿ‡บ๐Ÿ‡ธ USA
A$31.81 3.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.98 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.34 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$205.71 0.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$72.84 0.40%๐Ÿ‡ซ๐Ÿ‡ท France
A$45.89 0.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel